Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioLineRx (BLRX) Current Leases: 2023-2024

Historic Current Leases for BioLineRx (BLRX) over the last 2 years, with Dec 2024 value amounting to $522,000.

  • BioLineRx's Current Leases rose 489.84% to $998,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $998,000, marking a year-over-year increase of 489.84%. This contributed to the annual value of $522,000 for FY2024, which is 1.14% down from last year.
  • Per BioLineRx's latest filing, its Current Leases stood at $522,000 for FY2024, which was down 1.14% from $528,000 recorded in FY2023.
  • In the past 5 years, BioLineRx's Current Leases ranged from a high of $528,000 in FY2023 and a low of $522,000 during FY2024.
  • For the 2-year period, BioLineRx's Current Leases averaged around $525,000, with its median value being $525,000 (2023).
  • Data for BioLineRx's Current Leases shows a maximum YoY declined of 1.14% (in 2024) over the last 5 years.
  • Over the past 2 years, BioLineRx's Current Leases (Yearly) stood at $528,000 in 2023, then declined by 1.14% to $522,000 in 2024.